China Isotope & Radiation Corporation (HKG:1763)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.18
-0.22 (-1.08%)
Mar 9, 2026, 4:08 PM HKT
75.17%
Market Cap 6.46B
Revenue (ttm) 8.35B
Net Income (ttm) 464.77M
Shares Out 319.87M
EPS (ttm) 1.45
PE Ratio 13.89
Forward PE n/a
Dividend 0.43 (2.09%)
Ex-Dividend Date Oct 21, 2025
Volume 241,000
Average Volume 200,569
Open 20.08
Previous Close 20.40
Day's Range 19.80 - 20.54
52-Week Range 10.38 - 25.00
Beta 0.56
RSI 42.24
Earnings Date Mar 27, 2026

About China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmace... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1983
Employees 3,361
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1763
Full Company Profile

Financial Performance

In 2024, China Isotope & Radiation's revenue was 7.57 billion, an increase of 14.16% compared to the previous year's 6.63 billion. Earnings were 406.65 million, an increase of 9.62%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.